Our B16+ test series is a reliable method of diagnosing chronic Lyme disease. This diagnostic system consists of a combination of 16 tests which dramatically increases the probability of an accurate diagnosis compared to recommended tests. With this method, the percentage of Lyme disease infections detected is very high. The acknowledged inadequacies of standard tests and the risks of incorrect diagnosis based on "seronegative" findings are consequently largely ruled out.
Our combination of diagnostic methods has grown out of years of close cooperation between infected patients and experienced Lyme disease physicians and the results of scientific research.